The TFA seeks to establish trade and boost economic development through the four principles of simplification, standardisation, harmonisation and transparency of procedures so that it cuts the time and cost of conducting trade.
Patients who receive drug-eluting (coated) stents are recommended to take aspirin and one of these antiplatelet medications for at least a year after stent implantation. Taking aspirin and a second antiplatelet medication, such as Plavix, Effient, or Brilinta, is called dual antiplatelet therapy (DAPT). If you are a patient who is about to undergo a medical procedure with a physician other than the cardiologist who prescribed DAPT for you, be sure to talk with both doctors.
BRILINTA also reduces the rate of stent thrombosis in patients who have been stented for treatment of ACS. DOSING. In the management of ACS, initiate BRILINTA treatment with a 180-mg loading dose. Administer 90 mg twice daily during the first year after an ACS event. After one year administer 60 mg twice daily. Use BRILINTA with a daily maintenance dose of aspirin of 75-100 mg.